Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-32.7%
5Y CAGR-46.3%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-32.7%/yr
Annual compound
5Y CAGR
-46.3%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 8.91% |
| 2023 | -13.87% |
| 2022 | -5.10% |
| 2021 | 29.23% |
| 2020 | 14.68% |
| 2019 | 200.43% |
| 2018 | 0.00% |